サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


2019-2023 Asia-Pacific Nucleic Acid Testing (NAT) Analyzers and Reagents Market: A 17-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

アジア太平洋の核酸検査(NAT)アナライザーおよび試薬市場2019〜2023:17か国の分析‐企業シェアおよび戦略、検査数および売上予測、技術および機器レビュー

レポート概要

本レポートは、データパック(表のみの記載で分析テキストなし、12,500 USD)もございます。また、国、セクション、個々の検査、および市場セグメント別に購入可能であり、必要とする特定情報や予算に応じて特注できます。ご希望の場合はお問い合わせください。

分子診断市場は、インビトロ診断業界において、明らかに最も急成長しているセグメントです。今後5年間で、試薬システムおよび自動化において大きく進展し、革新的マーケティング手法を要する幅広い新製品が導入されるでしょう。しかしルーティン臨床ラボへの市場浸透率は、増幅手法を持つ費用効率の良い自動化システムの導入によります。同市場でのビジネスチャンスに成功裏に投資するため、多くの企業はすでに、ビジネスおよびマーケティング戦略のサポート管理された企業戦略アセットとしての新たな分子技術を活用しています。今後5年間、新たな技術をビジネスおよび企業戦略に統合する計画は、診断企業にとって最も困難な課題の1つとなるでしょう。

本レポートは、既存企業および潜在的な新規参入企業にとって、今後5年間の新たなビジネスチャンスを特定し、評価するのに役立つ情報を提供します。また、企業売上、市場シェア、5年検査数および売上予測、革新的技術や製品を開発している企業の戦略プロファイル、新規技術、アナライザーの総括、新たなビジネスチャンスなどについて取り上げます。

■調査範囲

  • 対象国:オーストラリア、バングラデシュ、中国、香港、インド、インドネシア、日本、マレーシア、ミャンマー、ニュージーランド、パキスタン、フィリピン、シンガポール、韓国、台湾、タイ、ベトナム
  • 売上および市場シェア分析
    ➣ 主要機器および試薬企業の売上および市場シェア分析
  • 市場セグメント分析
    ➣ 試薬および構成要素の主要企業に対する売上および市場シェア予測
    ➣ 以下の領域における主要アプリケーションの5年検査数および売上予測
      ◇ 感染症
      ◇ 法医学検査
      ◇ 癌
      ◇ 実父確定検査/HLAタイプ
      ◇ 遺伝子疾患
      ◇ その他
    ➣ 30超ものNATアッセイに対する5年検査数および売上予測
      ◇ 産業
      ◇ 学術
      ◇ 商業
    ➣ 市場ダイナミクス、動向、構造、規模、成長、および主要企業など、国別の市場セグメント分析
  • 製品/技術評価
    ➣ 以下の企業による主要アナライザーの比較:Abbott, Beckman Coulter, BD, Bio-Rad,Gen-Probe, Roche, Tecan
    ➣ 検査オートメーションおよび30超のターゲット/シグナル増幅手法における診断技術、検査フォーマット、検出手法、動向についての総括
      ◇ PCR
      ◇ bDNA
      ◇ NASBA
      ◇ TMA
      ◇ SSSR
      ◇ LCR
    ➣ 新たな技術や製品を開発している企業、大学、研究センターのリスト
  • ビジネスチャンスおよび戦略的提案
    ➣ 今後5年間の新たな製品開発機会と重要な市場アピール
    ➣ 新製品のデザイン基準
    ➣ 市場浸透戦略
    ➣ 潜在的な市場参入障壁とリスク
    ➣ 事業計画の課題と懸念
  • 競合評価
    ➣ 売上、製品ポートフォリオ、マーケティング戦略、協力協定、新製品/技術開発など、主な既存および新規参入企業の戦略評価
    ➣ 検査、アプリケーションごとに、分子診断製品を開発およびマーケティングしている企業の包括的なリスト
  • 調査手法
    ➣ 本レポートは、ラボディレクターや革新的技術や製品を開発している主要企業の幹部へのインタビュー、最新の技術およびビジネス出版物、メーカーの製品文書、財務文書、およびVPG社の独自のデータファイルなど、プライマリーおよびセカンダリー調査による情報を組み合わせています。

レポート詳細

目次

I. Introduction

II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products

III. Design Criteria for Decentralized Testing Products

IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing Markets

V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. Market and Technology Review
A. DNA Sequencing
 1. Introduction
 2. Sequencing Methods
 3. Autoradiography
 4. The Human Genome Project
 5. Sequencing Automation
 6. Image Scanners
 7. Fluorescent Detection
 8. Gene Profiling
 9. Gene Expression
 10. Polymorphism Screening
 11. Protein Interaction Networks
B. DNA and RNA Probe Technologies
 1. Basic Principles
 2. Probe Preparation
 3. The DNA Probe Test
 4. Test Formats
 5. Labeling Techniques
 6. Amplification Methods
C. Detection Technologies
 1. Radioactive Methods
  a. Overview
  b. Major Isotopes
 2. Non-Isotopic Methods
  a. Enzymatic Labels
  b. Chemical Labeling
  c. Fluorescence
  d. Chemiluminescence
  e. Electrical Conductivity
D. Molecular Diagnostic Instrumentation Review
 1. Abbott LCx
 2. Beckman Coulter/Biomek FK
 3. BD Viper System with XTR Technology
 4. BD Innova
 5. Becton Dickinson SDA
 6. bioMerieux NucliSENS easyMAG
 7. bioMerieux NucliSENS easyQ and MiniMAG
 8. Bio-Rad GeneScope
 9. Cepheid GeneXpert
 10. Curetis Unyvero
 11. GenMark Dx eSensor XT-8
 12. Hologic/Gen-Probe Panther
 13. Hologic/Gen-Probe Tigris/DTS
 14. HTG Molecular Edge
 15. Life Technologies QuantStudio Dx
 16. Qiagen QIAsymphony RGQ
 17. Roche Cobas Amplicor
 18. Roche Cobas TaqMan 48
 19. Roche Cobas TaqMan
 20. Roche Cobas TaqMan AmpliPrep
 21. Roche LighCycler 480
 22. Roche Cobas 4800
 23. Roche Cobas s 201
 24. Siemens Versant
 25. Tecan LS Series
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
   - Liquid Transportation and Mixing
   - Separation
   - Reaction
   - Detection
F. Pharmacogenomics
G. Major Applications
 1. Microbiology/Infectious Diseases
  a. Overview
  b. Major Infectious Diseases
   ° AIDS: HIV
   ° Adenovirus
   ° Aeromonas
   ° Anthrax/Bacillus Anthracis
   ° Arboviruses
   ° Babesiosis
   ° Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
   ° Blastocystis Hominis
   ° Brucella
   ° Campylobacter
   ° Candida
   ° Chagas Disease
   ° Chancroid
   ° Chlamydia
   ° Clostridium Difficile
   ° Coronaviruses
   ° Coxsackieviruses
   ° Creutzfeldt-Jakob’s Disease
   ° Cryptosporidium Parvum
   ° Cyclospora Cayetanensis
   ° Cytomegalovirus
   ° Ebola Virus
   ° E. Coli
   ° EchoVirus
   ° Encephalitis
   ° Enteroviruses
   ° Epstein-Barr Virus
   ° Giardia Lamblia
   ° Gonorrhea
   ° Granuloma Inguinale
   ° Hantavirus
   ° Helicobacter Pylori
   ° Hepatitis
   ° Herpes Simplex Virus
   ° Human Herpes Virus-6 (HHV-6)
   ° Influenza Viruses
   ° Legionella
   ° Lyme Disease
   ° Lymphogranuloma Venereum (LGV)
   ° Malaria
   °Measles (Rubeola)
   ° Meningitis
   ° Microsporidium
   ° Mononucleosis
   ° Mumps
   ° Mycoplasma
   ° Papillomaviruses
   ° Parvovirus B19
   ° Pneumonia
   ° Polyomaviruses
   ° Pseudomonas Aeruginosa
   ° Rabies
   ° Respiratory Syncytial Virus (RSV)
   ° Rhinoviruses
   ° Rotavirus
   ° Rubella
   ° Salmonellosis
   ° Septicemia
   ° Shigellosis
   ° Staphylococcus Aureus
   ° Streptococci
   ° Syphilis
   ° Toxoplasmosis
   ° Trichomonas Vaginalis
   ° Tuberculosis
   ° Vibrio
   ° West Nile Virus
   ° Yersinia
 2. Cancer Testing
  a. Overview
  b. Major Cancer Types
    * Prostate
    * Lung
    * Colon and Rectum
    * Breast
    * Skin
    * Uterine
    * Leukemia
    * Oral
  c. Oncogenes
    O Abl/abl-bcr
    O AIB1
    O BCL-2
    O BRCA1
    O CD44
    O C-fos
    O C-myb
    O C-myc
    O CYP17
    O Erb-B
    O HPC1
    O N-myc
    O P40
    O P51
    O P53
    O PIK3CA
    O PTI-1
    O Ras
    O Reg
    O Sis
    O Src
 3. Genetic Diseases
  a. Overview
  b. Nucleic Acid Amplification
  c. Chromosome Imaging
  d. Genomics Technologies
  e. Proteomics Technologies
  f. Current Pharmacogenomic Tests
  g. Future Pharmacogenomic Testing
  h. Major Diseases
    * Achondroplasia
    * Autosomal Dominant Polycystic Kidney Disease     * Cancer
    * Cosmetogenomics
    * Cystic Fibrosis
    * Down's Syndrome
    * Duchenne and Becker Muscular Dystrophy
    * Factor V (Leiden)
    * Factor IX Deficiency
    * Fragile X Syndrome
    * Heart Disease
    * Hemochomatosis
    * Hemophilia
    * Huntington's Disease
    * Maternal-Fetal Incompatibility
    * Multiple Endocrine Neoplasia
    * Phenylketonuria (PKU)
    * Polycystic Kidney Disease (PKD)
    * Prenatal Screening
    * Retinitis Pigmentosa
    * Retinoblastoma
    * Sickle Cell Anemia
    * Spinal Muscular Atrophy
    * Vitamin B12 Metabolism
  i. Social Issues and Concerns
 4. Forensic Testing
  a. Overview
  b. Multilocus and Single Locus Probes
  c. DNA Profile Data Banks
  d. Judicial Implementation
  e. Major Crime Categories
  f. Factors Contributing to the DNA Probe Market Expansion
   - Technology Availability
   - Use of Hair as Evidence
  g. Wildlife Forensics
 5. Paternity Testing/HLA Typing
 6. Other Applications
  a. Disease Susceptibility Testing
  b. Cardiovascular Diseases
  c. Diabetes
  d. Alzheimer's Disease
  e. Periodontal Disease
  f. Plasma Purification
  g. Organ Transplantation
  h. Water Contamination
  i. Other
H. Competing/complementing
 1. Monoclonal Antibodies/Immunoassays
 2. RNA Probes
 3. Two-Dimensional Electrophoresis
 4. Flow Cytometry

VII. Country Analyses: Volume and Sales Forecasts--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
 - Australia
 - Bangladesh
 - China
 - Hong Kong
 - India
 - Indonesia
 - Japan
 - Malaysia
 - Myanmar
 - New Zealand - Pakistan
 - Philippines
 - Singapore
 - South Korea
 - Taiwan
 - Thailand - Vietnam

VIII. Competitive Assessments
 - Abbott
 - Affymetrix/Thermo Fisher
 - Agilent Technologies
 - Applied Gene Technologies
 - Arca Biopharma
 - Beckman Coulter/Danaher
 - Becton Dickinson
 - Biokit
 - bioMerieux
 - Bio-Rad
 - Biotest
 - CellMark Forensics/LabCorp
 - Cepheid
 - Decode Genetics
 - Diadexus
 - Eiken
 - Elitech Group
 - Enzo
 - Exact Sciences
 - Fujirebio
 - Grifols
 - Hologic/Gen-Probe
 - Illumina
 - Kreatech/Leica
 - Li-Cor Biosciences
 - Monogram Biosciences/LabCorp
 - Myriad Genetics
 - Ortho-Clinical Diagnostics
 - Perkin Elmer/Caliper
 - Proteome Sciences
 - Qiagen
 - Roche
 - Scienion
 - Sequenom
 - Shimadzu
 - Siemens
 - Sierra Molecular
 - Takara Bio
 - Tecan Group

IX. Appendix: Major Universities and Research Centers Developing Innovative Molecular Diagnostic Technologies and Products

List of Tables
Australia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Australia Molecular Diagnostics Test Volume Forecasts by Application
Australia Major Infectious Disease Test Volume Forecasts by Assay
Australia Molecular Diagnostics Market Forecasts by Application
Australia Major Infectious Disease Diagnostics Market Forecasts by Assay
Bangladesh Molecular Diagnostics Test Volume and Sales Forecasts by Application
Bangladesh Molecular Diagnostics Test Volume Forecasts by Application
Bangladesh Major Infectious Disease Test Volume Forecasts by Assay
Bangladesh Molecular Diagnostics Market Forecasts by Application
Bangladesh Major Infectious Disease Diagnostics Market Forecasts by Assay
China Molecular Diagnostics Test Volume and Sales Forecasts by Application
China Molecular Diagnostics Test Volume Forecasts by Application
China Major Infectious Disease Test Volume Forecasts by Assay
China Molecular Diagnostics Market Forecasts by Application
China Major Infectious Disease Diagnostics Market Forecasts by Assay
Hong Kong Molecular Diagnostics Test Volume and Sales Forecasts by Application
Hong Kong Molecular Diagnostics Test Volume Forecasts by Application
Hong Kong Major Infectious Disease Test Volume Forecasts by Assay
Hong Kong Molecular Diagnostics Market Forecasts by Application
Hong Kong Major Infectious Disease Diagnostics Market Forecasts by Assay
India Molecular Diagnostics Test Volume and Sales Forecasts by Application
India Molecular Diagnostics Test Volume Forecasts by Application
India Major Infectious Disease Test Volume Forecasts by Assay
India Molecular Diagnostics Market Forecasts by Application
India Major Infectious Disease Diagnostics Market Forecasts by Assay
Indonesia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Indonesia Molecular Diagnostics Test Volume Forecasts by Application
Indonesia Major Infectious Disease Test Volume Forecasts by Assay
Indonesia Molecular Diagnostics Market Forecasts by Application
Indonesia Major Infectious Disease Diagnostics Market Forecasts by Assay
Japan Molecular Diagnostics Test Volume and Sales by Major Application
Japan Laboratories Performing DNA Sequencing by Market Segment
Japan Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Japan Molecular Diagnostics Test Volume by Major Application
Japan Major Infectious Disease Test Volume by Assay
Japan Major Infectious Disease Test Volume by Method
Japan Molecular Diagnostics Market by Major Application
Japan Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Japan Major Infectious Disease Diagnostics Market by Assay
Japan AIDS Testing Market Estimated Sales by Major Supplier
Japan Chlamydia Testing Market Estimated Sales by Major Supplier
Japan CMV Testing Market Estimated Sales by Major Supplier
Japan Gonorrhea Testing Market Estimated Sales by Major Supplier
Japan Hepatitis Testing Market Estimated Sales by Major Supplier
Japan Hepatitis C Testing Market Estimated Sales by Major Supplier
Japan Herpes Testing Market Estimated Sales by Major Supplier
Japan Meningitis Testing Market Estimated Sales by Major Supplier
Japan Mycoplasma Testing Market Estimated Sales by Major Supplier
Japan Pneumonia Testing Market Estimated Sales by Major Supplier
Japan Shigella Testing Market Estimated Sales by Major Supplier
Malaysia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Malaysia Molecular Diagnostics Test Volume Forecasts by Application
Malaysia Major Infectious Disease Test Volume Forecasts by Assay
Malaysia Molecular Diagnostics Market Forecasts by Application
Malaysia Major Infectious Disease Diagnostics Market Forecasts by Assay
Myanmar Molecular Diagnostics Test Volume and Sales Forecasts by Application
Myanmar Molecular Diagnostics Test Volume Forecasts by Application
Myanmar Major Infectious Disease Test Volume Forecasts by Assay
Myanmar Molecular Diagnostics Market Forecasts by Application
Myanmar Major Infectious Disease Diagnostics Market Forecasts by Assay
New Zealand Molecular Diagnostics Test Volume and Sales Forecasts by Application
New Zealand Molecular Diagnostics Test Volume Forecasts by Application
New Zealand Major Infectious Disease Test Volume Forecasts by Assay
New Zealand Molecular Diagnostics Market Forecasts by Application
New Zealand Major Infectious Disease Diagnostics Market Forecasts by Assay
Pakistan Molecular Diagnostics Test Volume and Sales Forecasts by Application
Pakistan Molecular Diagnostics Test Volume Forecasts by Application
Pakistan Major Infectious Disease Test Volume Forecasts by Assay
Pakistan Molecular Diagnostics Market Forecasts by Application
Pakistan Major Infectious Disease Diagnostics Market Forecasts by Assay
Philippines Molecular Diagnostics Test Volume and Sales Forecasts by Application
Philippines Molecular Diagnostics Test Volume Forecasts by Application
Philippines Major Infectious Disease Test Volume Forecasts by Assay
Philippines Molecular Diagnostics Market Forecasts by Application
Philippines Major Infectious Disease Diagnostics Market Forecasts by Assay
Singapore Molecular Diagnostics Test Volume and Sales Forecasts by Application
Singapore Molecular Diagnostics Test Volume Forecasts by Application
Singapore Major Infectious Disease Test Volume Forecasts by Assay
Singapore Molecular Diagnostics Market Forecasts by Application
Singapore Major Infectious Disease Diagnostics Market Forecasts by Assay
South Korea Molecular Diagnostics Test Volume and Sales Forecasts by Application
South Korea Molecular Diagnostics Test Volume Forecasts by Application
South Korea Major Infectious Disease Test Volume Forecasts by Assay
South Korea Molecular Diagnostics Market Forecasts by Application
South Korea Major Infectious Disease Diagnostics Market Forecasts by Assay
Taiwan Molecular Diagnostics Test Volume and Sales Forecasts by Application
Taiwan Molecular Diagnostics Test Volume Forecasts by Application
Taiwan Major Infectious Disease Test Volume Forecasts by Assay
Taiwan Molecular Diagnostics Market Forecasts by Application
Taiwan Major Infectious Disease Diagnostics Market Forecasts by Assay
Thailand Molecular Diagnostics Test Volume and Sales Forecasts by Application
Thailand Molecular Diagnostics Test Volume Forecasts by Application
Thailand Major Infectious Disease Test Volume Forecasts by Assay
Thailand Molecular Diagnostics Market Forecasts by Application
Thailand Major Infectious Disease Diagnostics Market Forecasts by Assay
Vietnam Molecular Diagnostics Test Volume and Sales Forecasts by Application
Vietnam Molecular Diagnostics Test Volume Forecasts by Application
Vietnam Major Infectious Disease Test Volume Forecasts by Assay
Vietnam Molecular Diagnostics Market Forecasts by Application
Vietnam Major Infectious Disease Diagnostics Market Forecasts by Assay
Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests for Genetic Diseases

発刊日

2019/01/31

体裁

PDF / 1240ページ

販売価格

16,500USD

発行

VPGMarketResearch

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はローカルライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

診断・検査薬

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE